Breaking News Instant updates and real-time market news.

FB

Facebook

$182.63

-1.14 (-0.62%)

14:49
04/24/19
04/24
14:49
04/24/19
14:49

Facebook options imply 9.7% move in share price post-earnings, above median historical move

Pre-earnings options volume in Facebook is 1.6x normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 9.7%, or $17.65, after results are released. Median move over the past eight quarters is 3.6%.

  • 24

    Apr

  • 30

    May

  • 03

    Jun

FB Facebook
$182.63

-1.14 (-0.62%)

04/22/19
CLVD
04/22/19
NO CHANGE
CLVD
Buy
Facebook 2019 estimates raised at Cleveland Research
Cleveland Research analyst Chandler Converse said his checks point to Q1 revenue for Facebook in-line with management's guidance for a mid-single digit deceleration in growth, but he also noted that advertisers seem incrementally more optimistic on the adoption of Stories ads. Additionally, partners appeared to slow plans to diversify budgets away from Facebook in the near-term given better ROI trends, said the analyst, who raised his 2019 estimates and keeps a Buy rating on the stock.
04/22/19
BARD
04/22/19
NO CHANGE
Target $195
BARD
Outperform
Facebook to report in-line to better-than-expected Q1, says Baird
Baird analyst Colin Sebastian expects Facebook to report in-line to better-than-expected Q1 results this week on the back of healthy advertiser demand. Sebastian tells investors in a research note that his firm's checks continue to suggest positive trends for the Facebook ecosystem, adding that Instagram is "particularly strong," despite headline concerns over platform privacy and safety. Management continues to highlight the growing contribution from new channels/formats while Messenger remains an area of increased focus, potentially a highlight at the upcoming F8 conference next week, he says. He maintains an Outperform rating and $195 price target.
04/23/19
FBCO
04/23/19
NO CHANGE
Target $211
FBCO
Outperform
Signs of potential value creation from Facebook new products, says Credit Suisse
Credit Suisse analyst Stephen Ju continues to anticipate the real clearing data point for Facebook shares will arrive on the Q3 report, in which he expects the OpEx/CapEx outlook to signal a return to growth for free cash flow. In the meantime, ahead of Q1 results, his checks continue to suggest minimal deceleration for U.S. budgets coupled with modest headwinds in Europe. Ju also believes there are "greater signs" of potential value creation from new products. The analyst reiterates an Outperform rating on the shares, while raising his price target on the stock to $211 from $210, as he believes Facebook will be able to drive long-term revenue growth without a material lift in ad loads with, the Street models continue to underestimate the long-term monetization potential of other billion-user properties like Messenger and WhatsApp, and free cash flow growth recovery for 2020.
04/24/19
OPCO
04/24/19
NO CHANGE
Target $44
OPCO
Outperform
Twitter price target raised to $44 from $33 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Twitter (TWTR) to $44 from $33 as platform improvements are driving mDAUs and monetization remains strong. The analyst notes that the company's machine learning initiatives have been proactive, flagging 38% of abusive Tweets before being seen. In general, the company has navigated public policy issues better than peers Alphabet (GOOG) and Facebook (FB), he contends. Helfstein reiterates an Outperform rating on Twitter's shares.

TODAY'S FREE FLY STORIES

XLF

Financial Select Sector

$26.97

-0.05 (-0.19%)

08:17
06/27/19
06/27
08:17
06/27/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$108.66

3.2 (3.03%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QQQ

Invesco QQQ Trust

$185.79

0.87 (0.47%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Technical Analysis
Invesco QQQ Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCEL

FuelCell

$0.18

0.0235 (15.31%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Hot Stocks
FuelCell announces new carbon capture project with Drax Power Station »

FuelCell Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$COMP

Nasdaq Composite

$0.00

(0.00%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Technical Analysis
Nasdaq Composite: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDX

Nasdaq 100 Index

$0.00

(0.00%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Technical Analysis
Nasdaq 100 Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLOIF

Soitec

$0.00

(0.00%)

08:15
06/27/19
06/27
08:15
06/27/19
08:15
Downgrade
Soitec rating change  »

Soitec downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:15
06/27/19
06/27
08:15
06/27/19
08:15
General news
Real GDP to be reported at 08:30 »

Real GDP will be reported…

08:15
06/27/19
06/27
08:15
06/27/19
08:15
General news
Jobless Claims to be reported at 08:30 »

Week of 6/22 Jobless…

08:15
06/27/19
06/27
08:15
06/27/19
08:15
General news
GDP Real Consumer Spending to be reported at 08:30 »

GDP Real Consumer…

CMFN

CM Finance

$7.08

-0.065 (-0.91%)

08:14
06/27/19
06/27
08:14
06/27/19
08:14
Conference/Events
CM Finance to hold a conference call »

Management announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTSI

VirTra

$2.38

(0.00%)

08:14
06/27/19
06/27
08:14
06/27/19
08:14
Hot Stocks
VirTra announces contract wins in Southern California »

VirTra has expanded its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$28.26

0.39 (1.40%)

08:13
06/27/19
06/27
08:13
06/27/19
08:13
Initiation
H&R Block initiated  »

H&R Block assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

WVE

Wave Life Sciences

$25.81

-0.08 (-0.31%)

08:13
06/27/19
06/27
08:13
06/27/19
08:13
Hot Stocks
Wave Life Sciences initiates DYSTANCE 51 trial of suvodirsen »

Wave Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORIT

Oritani Financial

$16.53

0.3 (1.85%)

08:13
06/27/19
06/27
08:13
06/27/19
08:13
Upgrade
Oritani Financial rating change  »

Oritani Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$6.14

-0.06 (-0.97%)

08:13
06/27/19
06/27
08:13
06/27/19
08:13
Hot Stocks
Aurinia Pharmaceuticals holder ILJIN comments on Aurinia annual meeting »

ILJIN, a founding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XNCR

Xencor

$39.14

0.57 (1.48%)

08:12
06/27/19
06/27
08:12
06/27/19
08:12
Hot Stocks
Xencor CMO Paul Foster to retire »

Xencor announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.55

-0.0424 (-7.19%)

08:12
06/27/19
06/27
08:12
06/27/19
08:12
Hot Stocks
Sunworks awarded follow-on order with Cibao Meat Products »

Sunworks announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$17.99

-0.015 (-0.08%)

08:11
06/27/19
06/27
08:11
06/27/19
08:11
Hot Stocks
SunGen Pharma partners with Athenex to launch Bivalirudin through PIV challenges »

SunGen Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

XERS

Xeris Pharmaceuticals

$10.64

-0.18 (-1.66%)

08:10
06/27/19
06/27
08:10
06/27/19
08:10
Hot Stocks
Xeris Pharmaceuticals doses first patient in ready-to-use glucagon Phase 2 trial »

Xeris Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Sep

  • 10

    Sep

CATB

Catabasis Pharmaceuticals

$7.67

0.17 (2.27%)

08:10
06/27/19
06/27
08:10
06/27/19
08:10
Hot Stocks
Catabasis Pharmaceuticals provides update on edasalonexent, qualitative research »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFOI

Energy Focus

$0.39

-0.0175 (-4.32%)

08:09
06/27/19
06/27
08:09
06/27/19
08:09
Hot Stocks
Energy Focus appoints Tod Nestor as president, CFO »

Energy Focus announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CURLF

Curaleaf Holdings

$0.00

(0.00%)

08:07
06/27/19
06/27
08:07
06/27/19
08:07
Hot Stocks
Curaleaf Holdings makes two separate acquisitions in Arizona for $25.5M »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATOS

Atossa Genetics

$2.27

-0.035 (-1.52%)

08:07
06/27/19
06/27
08:07
06/27/19
08:07
Hot Stocks
Atossa says preliminary Phase 2 study of Endoxifen achieves primary endpoint »

Atossa Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADNT

Adient

$23.19

1 (4.51%)

08:06
06/27/19
06/27
08:06
06/27/19
08:06
Initiation
Adient initiated  »

Adient initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.